Director, Digital Governance
McKesson
Work at Home - Tennessee, USA (WTNA)
Full-Time
Competitive
RemoteDirector
It’s More Than a Career, It’s a Mission.
Our people are the foundation of our success. By joining our growing team at Sarah Cannon Research Institute (SCRI), a subsidiary of McKesson, you will have the opportunity to become part of one of the largest community-based cancer programs to advance oncology treatments and improve outcomes for cancer patients across the globe. We look for mission-driven candidates who have a desire to advance the fight against cancer and make a difference in the lives of patients diagnosed with cancer every day.
Our Mission
People who live with cancer – those who work to prevent it, fight it, and survive it – are at the heart of every decision we make. Bringing the most innovative medical minds together with the most passionate caregivers in their communities, we are transforming care and personalizing treatment. Through clinical excellence and cutting-edge research, SCRI is redefining cancer care around the world.
The Director, Digital Governance is SCRI’s accountable owner for IT governance, including data, AI and agent governance, in a GxP clinical-research environment — designing and operating the lifecycle controls that govern AI and autonomous agents powering the Agent Factory, in alignment with Enterprise Governance standards. The role also owns SCRI’s data governance framework and operates IT SOPs as inspection-defensible controls, embedding governance directly into technology design, delivery, and operations.
This is a hands-on, build-and-run leadership role, directly accountable for design and execution and ensuring governance is actionable, automated where possible, and measurable — providing real-time visibility into AI accountability, data integrity, digital risk, and regulatory readiness through KPI-driven dashboards and inspection-ready controls.
Duties include but are not limited to:
Operate IT SOPs as inspection-defensible controls through ownership, SOP-to-control traceability, change-impact governance, and effectiveness monitoring.
Author, maintain, and operationalize IT SOPs and controlled documents to GxP, 21 CFR Part 11/Annex 11, and ALCOA+ expectations; ensure SCRI is audit- and inspection-ready on a continuous basis.
Design, build, and operate SCRI’sAI and agent governance framework, aligned with Enterprise controls and suitable for a GxP clinical-research environment.
Define and operationalize lifecycle governancefor AI and agentic systems: intended-use definition, model and agent documentation (model cards), validation, monitoring of non-deterministic behavior, and retirement/archival.
Establish governance requirements including clinical-expertise review for GxP AI, participant-disclosure handling for AI used in clinical trials, and model-archival protocols.
Partner with the Responsible AI Board/Office and Quality to translate Responsible AI principles into inspection-ready, executable controls for SCRI’s Agent Factory use cases.
Own SCRI’s data governance framework — policies, standards, and controls for data quality, integrity, lineage, and compliance.
Establish metadata, lineage, classification, and target="_blank">https://www.scri.com/careers/. Applications will be accepted through June 22nd, 2026. Please ensure all required materials are included as outlined in the posting.
About Sarah Cannon Research Institute
Sarah Cannon Research Institute (SCRI) is one of the world’s leading oncology research organizations conducting community-based clinical trials. Focused on advancing therapies for patients over the last three decades, SCRI is a leader in drug development. In 2022, SCRI formed a joint venture with former US Oncology Research to expand clinical trial access across the country. It has conducted more than 850 first-in-human clinical trials since its inception and contributed to pivotal research that has led to the majority of new cancer therapies approved by the FDA in the past decade. SCRI’s research network brings together more than 1,300 physicians who are enrolling patients into clinical trials at more than 200 locations in 20+ states across the U.S. Please click here to learn more about our research offerings.
We care about the well-being of the patients and communities we serve, and that starts with caring for our people. That’s why we have a Total Rewards package that includes comprehensive benefits to support physical, mental, and financial well-being. Our Total Rewards offerings serve the different needs of our diverse colleague population and ensure they are the healthiest versions of themselves. For more information regarding benefits through our parent company, McKesson, please click here.
As part of Total Rewards, we are proud to offer a competitive compensation package. This is determined by several factors, including performance, experience and skills, equity, regular job market evaluations, and geographical markets. In addition to base pay, other compensation, such as an annual bonus or long-term incentive opportunities may be offered.
McKesson has become aware of online recruiting-related scams in which individuals who are not affiliated with or authorized by McKesson are using McKesson’s (or affiliated entities, like CoverMyMeds or RxCrossroads) name in fraudulent emails, job postings or social media messages. In light of these scams, please bear the following in mind:
McKesson Talent Advisors will never solicit money or credit card information in connection with a McKesson job application.
McKesson Talent Advisors do not communicate with candidates via online chatrooms or using email accounts such as Gmail or Hotmail. Note that McKesson does rely on a virtual assistant (Gia) for certain recruiting-related communications with candidates.
McKesson job postings are posted on our career site: careers.mckesson.com.
We are an equal opportunity employer and value diversity at our company. We do not discriminate on the basis of race, religion, color, national origin, gender, sexual orientation, age, marital status, veteran status, or disability status.